Coronary artery bypass surgery in association with other cardiac procedures
Coronary Artery Bypass Surgery Microchapters | |
Pathophysiology | |
---|---|
Diagnosis | |
Treatment | |
Perioperative Monitoring | |
Surgical Procedure | |
Special Scenarios | |
Coronary artery bypass surgery in association with other cardiac procedures On the Web | |
FDA on Coronary artery bypass surgery in association with other cardiac procedures | |
CDC on Coronary artery bypass surgery in association with other cardiac procedures | |
Coronary artery bypass surgery in association with other cardiac procedures in the news | |
Blogs on Coronary artery bypass surgery in association with other cardiac procedures|- |
|
Risk calculators for Coronary artery bypass surgery in association with other cardiac procedures | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2] Anahita Deylamsalehi, M.D.[3]
Coronary Artery Bypass Surgery in Association with Other Cardiac Procedures
2021 ACA Revascularization Guideline[1]
Class 1 Recommendation, Level of Evidence:C-LD |
In a patient with significant coronary heart disease who is undergoing another cardiac surgery, such as valve surgery and aortic surgery, CABG is recommended with a goal of reducing ischemic events.[2][3][4][5][6][7][8][9][10][11][12] |
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (DO NOT EDIT)[13]
Class I |
"1. CABG is recommended in patients undergoing noncoronary cardiac surgery with greater than or equal to 50% luminal diameter narrowing of the left main coronary artery or greater than or equal to 70% luminal diameter narrowing of other major coronary arteries. (Level of Evidence: C)" |
Class IIa |
"1. The use of the LIMA is reasonable to bypass a significantly narrowed LAD artery in patients undergoing noncoronary cardiac surgery. (Level of Evidence: C)" |
"2. CABG of moderately diseased coronary arteries (>50% luminal diameter narrowing) is reasonable in patients undergoing noncoronary cardiac surgery. (Level of Evidence: C)" |
References
- ↑ Writing Committee Members. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM; et al. (2022). "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol. 79 (2): e21–e129. doi:10.1016/j.jacc.2021.09.006. PMID 34895950 Check
|pmid=
value (help). - ↑ Abel NJ, Rogal GJ, Burns P, Saunders CR, Chamberlain RS (2013). "Aortic valve replacement with and without coronary artery bypass graft surgery in octogenarians: is it safe and feasible?". Cardiology. 124 (3): 163–73. doi:10.1159/000346153. PMID 23467192.
- ↑ Agarwal S, Garg A, Parashar A, Svensson LG, Tuzcu EM, Navia JL; et al. (2015). "In-hospital mortality and stroke after surgical aortic valve replacement: A nationwide perspective". J Thorac Cardiovasc Surg. 150 (3): 571–8.e8. doi:10.1016/j.jtcvs.2015.05.068. PMID 26183193.
- ↑ Biancari F, Martin M, Bordin G, Vettore E, Vinco G, Anttila V; et al. (2014). "Basic data from 176 studies on the immediate outcome after aortic valve replacement with or without coronary artery bypass surgery". J Cardiothorac Vasc Anesth. 28 (5): 1251–6. doi:10.1053/j.jvca.2013.07.020. PMID 24290746.
- ↑ Carnero-Alcázar M, Reguillo-Lacruz F, Alswies A, Villagrán-Medinilla E, Maroto-Castellanos LC, Rodríguez-Hernández J (2010). "Short- and mid-term results for aortic valve replacement in octogenarians". Interact Cardiovasc Thorac Surg. 10 (4): 549–54. doi:10.1510/icvts.2009.218040. PMID 20100705.
- ↑ Di Gioia G, Pellicano M, Toth GG, Casselman F, Adjedj J, Van Praet F; et al. (2016). "Clinical Outcome of Patients with Aortic Stenosis and Coronary Artery Disease Not Treated According to Current Recommendations". J Cardiovasc Transl Res. 9 (2): 145–52. doi:10.1007/s12265-016-9680-6. PMID 26883368.
- ↑ Roberts WC, Roberts CC, Vowels TJ, Ko JM, Filardo G, Hamman BL; et al. (2012). "Effect of coronary bypass and valve structure on outcome in isolated valve replacement for aortic stenosis". Am J Cardiol. 109 (9): 1334–40. doi:10.1016/j.amjcard.2011.12.028. PMID 22386959.
- ↑ Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B; et al. (2013). "Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis". J Am Coll Cardiol. 61 (8): 837–48. doi:10.1016/j.jacc.2012.10.049. PMC 4262244. PMID 23428216.
- ↑ Shan L, Saxena A, McMahon R, Wilson A, Newcomb A (2013). "A systematic review on the quality of life benefits after aortic valve replacement in the elderly". J Thorac Cardiovasc Surg. 145 (5): 1173–89. doi:10.1016/j.jtcvs.2013.01.004. PMID 23415689.
- ↑ Vasques F, Lucenteforte E, Paone R, Mugelli A, Biancari F (2012). "Outcome of patients aged ≥80 years undergoing combined aortic valve replacement and coronary artery bypass grafting: a systematic review and meta-analysis of 40 studies". Am Heart J. 164 (3): 410–418.e1. doi:10.1016/j.ahj.2012.06.019. PMID 22980309.
- ↑ Thalji NM, Suri RM, Daly RC, Greason KL, Dearani JA, Stulak JM; et al. (2015). "The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era". J Thorac Cardiovasc Surg. 149 (2): 451–60. doi:10.1016/j.jtcvs.2014.08.073. PMID 25308117.
- ↑ Yamanaka K, Komiya T, Tsuneyoshi H, Shimamoto T (2016). "Outcomes of Concomitant Total Aortic Arch Replacement with Coronary Artery Bypass Grafting". Ann Thorac Cardiovasc Surg. 22 (4): 251–7. doi:10.5761/atcs.oa.16-00056. PMC 5045853. PMID 27237968.
- ↑ Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG; et al. (2011). "2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e31823c074e. PMID 22064599.